Prostate Cancer - Results from #27140

Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups - Abstract September 16, 2011

Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: Diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging - Abstract September 16, 2011

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract September 16, 2011

Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract September 16, 2011

The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy - Abstract September 16, 2011

Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract September 16, 2011

Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone - Abstract September 16, 2011

Gleason score 7 prostate cancer on needle biopsy: Relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy - Abstract September 15, 2011

Emerging therapies to prevent skeletal morbidity in men with prostate cancer - Abstract September 15, 2011

Construct validity in a high-fidelity prostate exam simulator - Abstract September 15, 2011

Role of pelvic lymph node dissection in prostate cancer treatment - Abstract September 15, 2011

Prostate-specific antigen testing across the spectrum of prostate cancer - Abstract September 15, 2011

Active-targeted nanotherapy strategies for prostate cancer - Abstract September 15, 2011

Bone scan can be spared in asymptomatic prostate cancer patients with PSA of ct September 15, 2011

Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT - Abstract September 14, 2011

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance - Abstract September 14, 2011

T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy - Abstract September 14, 2011

Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates - Abstract September 14, 2011

Determination of action thresholds for electromagnetic tracking system-guided hypofractionated prostate radiotherapy using volumetric modulated arc therapy - Abstract September 14, 2011

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer - Abstract September 14, 2011

Page 1358 of 1437